ArticleJournal of medicinal chemistry2026
Development of a Second-Generation RARα Selective Antagonist as an Orally Bioavailable, Effective, Safe, and Reversible Male Contraceptive.
Rui Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.